340 B Drug Pricing Program
The 340B Program provides discounts on outpatient drugs to certain safety net health providers, including Title X agencies. The program's intent is to allow safety net providers to increase patient services with the savings realized from participation in the 340B program. Providers typically save 25-50% on outpatient drug costs through participation in the program. These savings can be used to reduce the price of pharmaceuticals for patients, expand services offered to patients, or provide services to more patients.
Outpatient prescription drugs, over the counter drugs (accompanied by a prescription), and clinic-administered drugs within eligible facilities are covered. Vaccines and inpatient drugs are not covered.
There is no risk or cost to providers for participating in the program.
For program details, visit:
Office of Pharmacy Affairs (OPA) website
For technical assistance:
Pharmacy Services Support Center (PSSC)
OPA Recertification Program Manager:
LCDR Joshua E. Hardin MBA, BSN, MLT
- January 30, 2012 - Email with passwords will be sent. Title X Service Grantee Representatives will verify if covered entities under grant numbers associated to them are eligible to remain in the 340B program. Required verification deadline will be 1200EST February 10, 2012.
- February 11, 2012 - Regional Program Consultants (RPCs) for the ten HHS Regions will verify the Service Grantee Representatives are the appropriate designees to make verification determinations. Required verification deadline for RPCs will be 1200 EST February 24, 2012.
- February 25, 2012 - HRSA Office of Pharmacy Affairs will begin final recertification
The following resources provide more information about the program for Title X providers:
Content last reviewed on August 17, 2016